Futura Medical (LON:FUM) Trading 18.7% Higher – Time to Buy?

Shares of Futura Medical plc (LON:FUM) shot up 18.7% on Wednesday . The company traded as high as GBX 0.75 and last traded at GBX 0.71. 339,071 shares were traded during mid-day trading, a decline of 95% from the average session volume of 6,199,237 shares. The stock had previously closed at GBX 0.60.

Futura Medical Stock Up 5.8%

The business’s fifty day moving average is GBX 1.02 and its two-hundred day moving average is GBX 1.20. The stock has a market capitalization of £3.69 million, a PE ratio of -0.23 and a beta of 0.01.

Futura Medical (LON:FUM) last posted its earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. The business had revenue of GBX 170 million during the quarter. Sell-side analysts expect that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.